Oral realgar in the treatment of patients with myelodysplastic syndrome

Zhong-yang Deng, Ming-jing Wang, Xiao-mei Hu

Abstract


Chinese arsenic drugs have been applied in Chinese medicine for several centuries. Active ingredients of realgar is As2S2. Oral realgar has been widely used in the treatment of myelodysplastic syndrome (MDS) with obvious Chinese characteristics, and the good clinical outcomes have been achieved. Decreasing the gastrointestinal adverse reactions of realgar can not only increase tolerance of patient to realgar, but improve the clinical efficacy, which will ensure the safety of oral realgar for clinical use, as well as open a new vision for the treatment of MDS.

Keywords


Realgar; arsenic; Chinese medicine; Myelodysplastic syndrome

Full Text:

PDF (简体中文)


DOI: http://dx.doi.org/10.14725/gjtm.v3n1a1224

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

Global Journal of Traditional Medicine 

ISSN 2308-5665 (Print)  ISSN ****-**** (Online)